company

STIFTELSEN FOR Å FREMME FORSKNING INNEN FUNKSJONELL VITAMIN B 12-MANGEL

5014 BERGEN

Return on Equity
−14,87 %
Current Ratio
13,52
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue0
Net Income−3 026 000
Total Assets20 493 000
Total Equity20 354 000
Income (NOK)2022
Revenue0
Expenditure3 327 000
Operating Profit−3 326 000
Financial Income303 000
Financial Costs2 000
Financial Balance301 000
Earnings Before Tax−3 026 000
Tax0
Net Income−3 026 000
Balance (NOK)2022
Total Fixed Assets18 600 000
Total Current Assets1 893 000
Total Assets20 493 000
Total Retained Equity20 154 000
Total Equity20 354 000
Total Long-Term Debt0
Total Current Debt140 000
Total Equity and Debt20 493 000
Cash flow (NOK)2022
Sales Income0
Other Income0
Revenue0
Cost of Goods Sold0
Salary Costs304 000
Depreciation0
Impairment0
Expenditure3 327 000
Operating Profit−3 326 000
Financial Income303 000
Financial Costs2 000
Financial Balance301 000
Dividends−1 187 000
Net Income−3 026 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets18 600 000
Total Fixed Assets18 600 000
Stock0
Total Investments0
Cash, Bank6 000
Total Current Assets1 893 000
Total Assets20 493 000
Total Equity20 354 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors52 000
Unpaid Taxes0
Dividends−1 187 000
Other Current Debt88 000
Total Current Debt140 000
Total Equity and Debt20 493 000
Financial indicators2022
Return on Equity−14,87 %
Debt-to-Equity Ratio0
Operating Profit Margin-
Current Ratio13,52
Quick Ratio13,52
Equity Ratio0,99
Gross Profit Margin-
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English